Apply now for one year free bench space!
Revel has tapped the Agilent Instrument Subscriptions Program to gain access to a mass spectrometer, critical in the startup’s work to combat the damages of aging.
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures
Soteria, a privately-held, immuno-oncology company focused on developing a next generation of switchable bispecific T-cell engagers to treat patients with solid tumor cancers, announces $42 Million Series A Financing.
Alessa Therapeutics Announces First Australian Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer
Alessa Therapeutics announces the enrollment of the first patient in their clinical study in Australia. The Biolen-PC study will treat up to 20 patients in Australia and New Zealand.
MBC BioLabs is excited to announce a strategic partnership with Fujifilm Open Innovation Hub to support biotech collaboration and innovation in our startup ecosystem.
Mammoth Biosciences Raises $68M for its CRISPR Diagnostics